Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Vitamin D3 in HIV and Smokers
NCT03270709Phase 1Terminated
- Sponsor
- Emory University
- Start
- Apr 2018
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label trial of vitamin d in human immunodeficiency virus infection (HIV) and Vitamin D deficiency (VDD), sponsored by Emory University. Started Apr 2018; status: terminated.
02
Drugs
vitamin d
03
Conditions
human immunodeficiency virus infection (HIV)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03270709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270709.